Photographer: Ariadna Pujol
A distinctive pharmaceutical company
Our adventure began in Barcelona in 2003, when three friends in their twenties decided to start up in the pharmaceutical sector. At a time when the dotcoms were proliferating, Galenicum broke into a fairly traditional space.
Even though in the beginning, the business of Galenicum was limited to trading of active pharmaceutical ingredients (APIs) for generics’ companies in Spain, the activity very quickly expanded to encompass the full value chain, including: research and development, regulatory affairs, manufacturing and supply of a broad range of medicines in any part of the world.
Our positioning as ‘specialty pharma’ sums up our ambition in research and development, as well as in operations to fulfil our purpose: to keep improving the quality and affordability of medicines worldwide.
An entrepreneurial free-spirit along with a close, reliable and flexible service to clients, have driven our conscious growth since day one. Today, Galenicum is an ecosystem of several businesses with commercial presence in over fifty countries, covering the full pharmaceutical value chain.
Value Chain
Trading of Active Pharmaceutical Ingredients (APIs)
Intellectual Property and Patents
Research and Development of Finished Dosage Forms (FDFs)
Regulatory Affairs
Manufacturing
Supply and Commercialisation
The Grand Journey
‘The Grand Journey’ is the first episode of a trilogy of short films around the renovation of an old industrial warehouse, which has become the new Galenicum headquarters and R&D Center in 2022.
Our History
2003
2022
-
2003
GALENICUM IS FOUNDED IN BARCELONA
-
2007
First authorisation of generic products in Spain
-
2009
Awarding of the first patent for Galenicum
-
2010
Incorporation of the GSI branch of food ingredients
-
2012
Opening of offices in Chile, Peru and Brazil
-
2013
Acquisition of the production plant in Madrid - SAG
Launch of our own B2C brand Galenicum ‘Vitae’ -
2014
Recognition as ‘Business of the Year’ in the European Business Awards
-
2015
Incorporation of the dermatological business branch, Galenicum Derma
-
2016
Launch of the food supplement line
-
2018
First product developed by Galenicum approved by the US FDA.
Opening of office in Colombia. -
2019
Creation of the ‘Galenicum Ecosystem’ to reorganise and boost the business and operations
-
2020
Management of the COVID-19 crisis, recognized as one of the top suppliers
-
2021
New site openings: India, Ecuador and Mexico
-
2022
Pergamon. Our New headquarters. Gliptins Launch globally. New affiliate in UAE (WIP)
